Category : Search result: pharmaceutical revenue


Unauthorized Drugs Seized from Vancouver Gym

Health Canada enforcement officers have seized unauthorized pharmaceutical drugs from a Vancouver fitness facility. Discover the details of the raid and the ongoing risks of unregulated substances.

FDA Approves Wegovy Weight Loss Pill

U.S. regulators have approved the Wegovy pill for weight loss, a major development in pharmaceutical treatment. Learn about the details and potential impact of this new drug.

Fox Host Debunks Trump's 600% Drug Price Cut Claim

A Fox News anchor delivered a brutal math lesson on air, highlighting the impossibility of Trump's claim about slashing prescription drug prices by 600%. See the reality vs. perception clash unfold.

Feds move $900M pension surplus, total hits $2.8B

The federal government is moving another $900 million surplus from the public service pension fund to a central account, bringing the total to $2.8 billion. Public sector unions are alarmed. Read more.

Accenture Beats Q1 Revenue Estimates on AI Demand

Accenture exceeded Wall Street's first-quarter revenue expectations, driven by robust demand for its AI-powered IT services. The company is advancing its strategy to capture greater market share.

Edmonton may charge for parking at city attractions

Edmonton councillor proposes study on implementing parking fees at city-owned attractions like the zoo and science centre to recover costs and reduce property tax pressure. Could this be a new reality for a growing city?

Health Canada Approves Drug for Rare Disease

Health Canada has granted approval for a new pharmaceutical treatment targeting a rare disease, offering hope for patients. Learn about the regulatory decision and its impact.

Pfizer 2026 profit forecast below expectations

Pfizer projects 2026 profits below Wall Street estimates due to a steep drop in COVID product sales and loss of exclusivity for key drugs. Get the full business analysis.

CRA warns of aggressive tax schemes in Canada

The Canada Revenue Agency has issued a public alert about aggressive tax avoidance schemes operating in the country. Learn what to watch for and how to protect yourself.

Delta Air Lines lost $200M in U.S. shutdown

The longest U.S. government shutdown cost Delta Air Lines an estimated $200 million in revenue. The airline cites reduced travel demand from federal employees and contractors.

China's Biopharma Surge Challenges Global Drug Leaders

China's biopharma industry is accelerating, fueled by record investment and streamlined supply chains. With faster development times and massive deals like AstraZeneca's $5.2B pact, the global drug innovation race is heating up. Discover the shift from ou

Eli Lilly cuts price of obesity drug Zepbound

Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.

Economist Calls Trump's Economic Claims 'Nonsense'

University of Michigan economist Justin Wolfers dismantles Donald Trump's recent economic boasts, calling them misleading and highlighting weak consumer confidence. Read the full analysis.

Page 1 of 4